RE: An introduction to Kerato Ltd, a BSF Enterprises subsidiary, focussing on corneal regeneration8 Nov 2024 14:01
Just watched the video, this is a very exciting treatment which could change the lives of many animals and people. Commercialisation in 2025, Sarah seems very experienced in commercialising this type of product and with revenue around the corner this Mcap looks incredibly low. Have held this share for a couple of years and watched the SP slowly fall, will soon rerate and patience will be rewarded.